Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermany
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Dermatology"
DOI: 10.1111/bjd.18958
Abstract: The German atopic eczema (AE)-registry TREATgermany is a non-interventional multicenter patient cohort study for adult patients with currently moderate-to-severe disease activity or current/previous anti-inflammatory systemic treatment.1,2 Dupilumab has demonstrated to be an effective treatment for… read more here.
Keywords: dupilumab; registry treatgermany; atopic eczema; routine care ... See more keywords